Bruce Tromberg (right), director of the Beckman Laser Institute, and UCI oncologists John Butler, David Hsiang and Rita Mehta (from left) are evaluating a breast imaging device that produces metabolic “fingerprints.”
In 2003, researchers at UC Irvine’s Beckman Laser Institute received a $7 million grant from the National Cancer Institute to standardize use of a laser imaging device they had created for better detection and diagnosis of breast cancer. The investment is beginning to pay off.
In January, the researchers reported in the journal Radiology that this laser breast scanner can accurately distinguish between malignant and benign growths, possibly offering an easy, noninvasive way to tell whether breast tumors warrant aggressive treatment. The study involved 60 subjects and will be replicated with a larger test group. Continue Reading »

